SCHEMBL23444958

SCHEMBL23444958

Cc1cc2c(cc1Nc1cccc(C(C)C)c1)C(C)(C)CCC2(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 1/20 0.41
▸ RXRA P19793 4/20 0.37
▸ JAK2 O60674 2/20 0.37
▸ CYP26A1 O43174 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ ICMT O60725 1/20 0.35
▸ BUB1 O43683 1/20 0.35
▸ GRIN2D O15399 1/20 0.35
▸ GRIN3B O60391 1/20 0.35
▸ GRIN1 Q05586 1/20 0.35
▸ GRIN2A Q12879 1/20 0.35
▸ GRIN2B Q13224 1/20 0.35
▸ GRIN2C Q14957 1/20 0.35
▸ GRIN3A Q8TCU5 1/20 0.35
▸ SIGMAR1 Q99720 1/20 0.35
▸ EGFR P00533 1/20 0.34
▸ TNNI3K Q59H18 1/20 0.34
▸ PRKCB P05771 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24772162 0.83 NPSR1 (0.46) MEN1KMT2AHNF4A
SCHEMBL23927549 0.78 KIF11 (0.41) KIF11RXRACYP26A1ICMTBUB1
SCHEMBL23371572 0.78 CYP26A1 (0.44) RXRAJAK2CYP26A1MEN1TSHR
SCHEMBL29760994 0.76 GAA (0.37) RXRACYP26A1MEN1KMT2AHNF4A
SCHEMBL24561834 0.76 GAA (0.37) RXRACYP26A1MEN1KMT2AHNF4A
SCHEMBL23927691 0.75 RXRA (0.41) RXRACYP26A1MEN1KMT2ARARA
SCHEMBL28481448 0.75 EGFR (0.42) RXRACYP26A1MEN1KMT2AEGFR
SCHEMBL23439405 0.74 CYP26A1 (0.42) RXRAJAK2CYP26A1MEN1TSHR
SCHEMBL23421097 0.74 CYP26A1 (0.38) RXRAJAK2CYP26A1MEN1TSHR
SCHEMBL24562676 0.73 RXRA (0.42) RXRACYP26A1MEN1KMT2ARARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11685751-B2 Compound and organic light-emitting element comprising same LG CHEM, LTD. (KR) 2023-06-27 — — US disclosed
US-11685751-B2 Compound and organic light-emitting element comprising same LG CHEM, LTD. (KR) 2023-06-27 — — US disclosed
US-20230061019-A1 COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2023-03-02 — — US disclosed
WO-2021107680-A1 COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME 주식회사 엘지화학 2021-06-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230061019-A1 COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, LEF1 KIF11 3344/4885RXRA 1028/4885JAK2 3258/4885
US-11685751-B2 Compound and organic light-emitting element comprising same CRY1, CRY2, LEF1 KIF11 3344/4885RXRA 1028/4885JAK2 3258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback